Callio Therapeutics develops multi-payload antibody-drug conjugates for cancer therapy.

Alleviant Medical, Inc. develops minimally invasive medical devices for treating heart failure, specifically through a no-implant atrial shunt.

Windward Bio is a clinical-stage drug development company focused on creating treatments for severe respiratory conditions, including asthma and COPD, using long-acting monoclonal antibodies and bispecifics.

Aviceda Therapeutics is a biotech company developing next-generation immunomodulators for ophthalmic conditions using its proprietary HALOS™ nanotechnology platform.

nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.

XII Medical, Inc. develops innovative neuromodulation therapies for obstructive sleep apnea.

ARTBIO is a clinical-stage biotech firm specializing in developing alpha radioligand therapies for cancer treatment, currently advancing its proprietary technology and lead prostate cancer program through clinical trials.

EyeBio is a clinical-stage ophthalmology biotechnology company focused on developing therapies for sight-threatening eye diseases and has expanded its Series A funding to $130 million.

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.